112 related articles for article (PubMed ID: 32665185)
41. Disparities in cancer treatment among patients infected with the human immunodeficiency virus.
Suneja G; Lin CC; Simard EP; Han X; Engels EA; Jemal A
Cancer; 2016 Aug; 122(15):2399-407. PubMed ID: 27187086
[TBL] [Abstract][Full Text] [Related]
42. Should HIV-positive patients with lymphoma be offered stem cell transplants?
Krishnan A; Zaia J; Forman SJ
Bone Marrow Transplant; 2003 Oct; 32(8):741-8. PubMed ID: 14520416
[TBL] [Abstract][Full Text] [Related]
43. Post-autologous transplant maintenance therapies in lymphoid malignancies: are we there yet?
Epperla N; Fenske TS; Lazarus HM; Hamadani M
Bone Marrow Transplant; 2015 Nov; 50(11):1393-404. PubMed ID: 26281033
[TBL] [Abstract][Full Text] [Related]
44. Outcomes of HIV-associated Hodgkin lymphoma in the era of antiretroviral therapy.
Olszewski AJ; Castillo JJ
AIDS; 2016 Mar; 30(5):787-96. PubMed ID: 26730566
[TBL] [Abstract][Full Text] [Related]
45. Risk of cancer among HIV-infected patients from a population-based nested case-control study: implications for cancer prevention.
Chen CH; Chung CY; Wang LH; Lin C; Lin HL; Lin HC
BMC Cancer; 2015 Mar; 15():133. PubMed ID: 25885746
[TBL] [Abstract][Full Text] [Related]
46. Hematopoietic cell transplantation for systemic mature T-cell non-Hodgkin lymphoma.
Smith SM; Burns LJ; van Besien K; Lerademacher J; He W; Fenske TS; Suzuki R; Hsu JW; Schouten HC; Hale GA; Holmberg LA; Sureda A; Freytes CO; Maziarz RT; Inwards DJ; Gale RP; Gross TG; Cairo MS; Costa LJ; Lazarus HM; Wiernik PH; Maharaj D; Laport GG; Montoto S; Hari PN
J Clin Oncol; 2013 Sep; 31(25):3100-9. PubMed ID: 23897963
[TBL] [Abstract][Full Text] [Related]
47. Toxicity and efficacy of autologous hematopoietic cell transplantation in elderly patients with aggressive lymphoma: a historical prospective study.
Davidov M; Perry C; Herishanu Y; Sarid N; Rom E; Amit O; Eshel R; Naparstek E; Avivi I; Ram R
Ann Hematol; 2018 Mar; 97(3):459-466. PubMed ID: 29177562
[TBL] [Abstract][Full Text] [Related]
48. Management and outcome of primary CNS lymphoma in the modern era: An LOC network study.
Houillier C; Soussain C; Ghesquières H; Soubeyran P; Chinot O; Taillandier L; Lamy T; Choquet S; Ahle G; Damaj G; Agapé P; Moluçon-Chabrot C; Amiel A; Delwail V; Fabbro M; Jardin F; Chauchet A; Moles-Moreau MP; Morschhauser F; Casasnovas O; Gressin R; Fornecker LM; Abraham J; Marolleau JP; Tempescul A; Campello C; Colin P; Tamburini J; Laribi K; Serrier C; Haioun C; Chebrek S; Schmitt A; Blonski M; Houot R; Boyle E; Bay JO; Oberic L; Tabouret E; Waultier A; Martin-Duverneuil N; Touitou V; Cassoux N; Kas A; Mokhtari K; Charlotte F; Alentorn A; Feuvret L; Le Garff-Tavernier M; Costopoulos M; Mathon B; Peyre M; Delgadillo D; Douzane H; Genet D; Aidaoui B; Hoang-Xuan K; Gyan E
Neurology; 2020 Mar; 94(10):e1027-e1039. PubMed ID: 31907289
[TBL] [Abstract][Full Text] [Related]
49. Reduced-Intensity Transplantation for Lymphomas Using Haploidentical Related Donors Versus HLA-Matched Sibling Donors: A Center for International Blood and Marrow Transplant Research Analysis.
Ghosh N; Karmali R; Rocha V; Ahn KW; DiGilio A; Hari PN; Bachanova V; Bacher U; Dahi P; de Lima M; D'Souza A; Fenske TS; Ganguly S; Kharfan-Dabaja MA; Prestidge TD; Savani BN; Smith SM; Sureda AM; Waller EK; Jaglowski S; Herrera AF; Armand P; Salit RB; Wagner-Johnston ND; Fuchs E; Bolaños-Meade J; Hamadani M
J Clin Oncol; 2016 Sep; 34(26):3141-9. PubMed ID: 27269951
[TBL] [Abstract][Full Text] [Related]
50. A Phase II Trial of Fludarabine/Melphalan 100 Conditioning Therapy Followed by Allogeneic Hematopoietic Cell Transplantation for Patients With Lymphoma.
Lee JH; Lee JH; Kim DY; Seol M; Lee YS; Kang YA; Jeon M; Lee KH
Clin Lymphoma Myeloma Leuk; 2015 Nov; 15(11):655-63. PubMed ID: 26428486
[TBL] [Abstract][Full Text] [Related]
51. Immune recovery after autologous stem cell transplantation is not different for HIV-infected versus HIV-uninfected patients with relapsed or refractory lymphoma.
Simonelli C; Zanussi S; Pratesi C; Rupolo M; Talamini R; Caffau C; Teresa Bortolin M; Tedeschi R; Basaglia G; Mazzucato M; Manuele R; Vaccher E; Spina M; Tirelli U; Michieli M; De Paoli P
Clin Infect Dis; 2010 Jun; 50(12):1672-9. PubMed ID: 20450419
[TBL] [Abstract][Full Text] [Related]
52. The Impact of Palifermin Use on Hematopoietic Cell Transplant Outcomes in Children.
Saber W; Zhang MJ; Steinert P; Chen M; Horowitz MM
Biol Blood Marrow Transplant; 2016 Aug; 22(8):1460-1466. PubMed ID: 27090960
[TBL] [Abstract][Full Text] [Related]
53. Does the hematopoietic cell transplantation specific comorbidity index (HCT-CI) predict transplantation outcomes? A prospective multicenter validation study of the Kanto Study Group for Cell Therapy.
Nakaya A; Mori T; Tanaka M; Tomita N; Nakaseko C; Yano S; Fujisawa S; Sakamaki H; Aotsuka N; Yokota A; Kanda Y; Sakura T; Nanya Y; Saitoh T; Kanamori H; Takahashi S; Okamoto S
Biol Blood Marrow Transplant; 2014 Oct; 20(10):1553-9. PubMed ID: 25034961
[TBL] [Abstract][Full Text] [Related]
54. Postrelapse survival in diffuse large B-cell lymphoma after therapy failure following autologous transplantation.
Epperla N; Badar T; Szabo A; Vaughn J; Borson S; Saini NY; Patel RD; Shah NN; Hamadani M; Ahmed S; Cashen AF; Fenske TS
Blood Adv; 2019 Jun; 3(11):1661-1669. PubMed ID: 31167818
[TBL] [Abstract][Full Text] [Related]
55. Autologous stem cell transplantation for HIV-associated lymphoma in the antiretroviral and rituximab era: a retrospective study by the EBMT Lymphoma Working Party.
Hübel K; Re A; Boumendil A; Finel H; Hentrich M; Robinson S; Wyen C; Michieli M; Kanfer E; Diez-Martin JL; Balsalobre P; Vincent L; Schroyens W; Santasusana JMR; Kröger N; Schiel X; Cwynarski K; Esquirol A; Sousa AB; Cattaneo C; Montoto S; Dreger P
Bone Marrow Transplant; 2019 Oct; 54(10):1625-1631. PubMed ID: 30804486
[TBL] [Abstract][Full Text] [Related]
56. Early CD4+ T cell reconstitution as predictor of outcomes after allogeneic hematopoietic cell transplantation.
van Roessel I; Prockop S; Klein E; Boulad F; Scaradavou A; Spitzer B; Kung A; Curran K; O'Reilly RJ; Kernan NA; Cancio M; Boelens JJ
Cytotherapy; 2020 Sep; 22(9):503-510. PubMed ID: 32622752
[TBL] [Abstract][Full Text] [Related]
57. A modified EBMT risk score and the hematopoietic cell transplantation-specific comorbidity index for pre-transplant risk assessment in adult acute lymphoblastic leukemia.
Terwey TH; Hemmati PG; Martus P; Dietz E; Vuong LG; Massenkeil G; Dörken B; Arnold R
Haematologica; 2010 May; 95(5):810-8. PubMed ID: 20007143
[TBL] [Abstract][Full Text] [Related]
58. Hematopoietic cell transplantation comorbidity index (HCT-CI) is predictive of adverse events and overall survival in older allogeneic transplant recipients.
Keller JW; Andreadis C; Damon LE; Kaplan LD; Martin TG; Wolf JL; Ai WZ; Venstrom JM; Smith CC; Gaensler KM; Hwang J; Olin RL
J Geriatr Oncol; 2014 Jul; 5(3):238-44. PubMed ID: 24894413
[TBL] [Abstract][Full Text] [Related]
59. The effectiveness of rituximab and HIV on the survival of Ontario patients with diffuse large B-cell lymphoma.
Habbous S; Guo H; Beca J; Dai WF; Isaranuwatchai W; Cheung M; Chan KKW
Cancer Med; 2020 Oct; 9(19):7072-7082. PubMed ID: 32794362
[TBL] [Abstract][Full Text] [Related]
60. Characteristics and Trends of Adult Acute Lymphoblastic Leukemia in a Large, Public Safety-Net Hospital.
Gupta R; Othman T; Uche A; Amanam I; Chen C; Celles L; Lane G; Mei M; Aldoss I; Pullarkat V; Kim P; Yeh J
Clin Lymphoma Myeloma Leuk; 2020 Jun; 20(6):e320-e327. PubMed ID: 32199763
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
